Advanced search×

No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.

Maria S MS Felice, Jorge G JG Rossi, Marta S MS Gallego, Elizabeth M EM Alfaro, Pedro A PA Zubizarreta, Lidia E LE Fraquelli, Cristina N CN Alonso, Myriam R MR Guitter, and Marcelo J MJ Scopinaro

Pediatr Blood Cancer 57(1):47-55 (2011) PMID 21394895

Our aim was to compare two different schedules of maintenance in pediatric acute lymphoblastic leukemia (ALL) treated with a BFM-based therapy, in a randomized study: an Arm with 6-MP + MTX (with or without vincristine and dexamethasone pulses) versus a more intensive continuation phase.

DOI: 10.1002/pbc.23097
Version: za2963e q8zae q8zb1 q8zc7 q8zdf q8zeb q8zfc q8zge
Buy PDF

Similar articles you may find interesting…

  1. The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
    S Sozer, M I Fiel, ... R Hoffman

    Blood 113(21):5246-5249 (2009) PMID 19293426

    We explored whether JAK2V617F was present in ECs in the vessels of polycythemia vera (PV) patients with BCS using laser capture microdissection followed by nested polymerase chain reaction or reverse-transcribed polymerase chain reaction. The ECs of the 2 BCS patients with PV were homozygous for the...
    Buy PDF
  2. Evidence for a molecular complex consisting of Fyb/SLAP, SLP-76, Nck, VASP and WASP that links the actin cytoskeleton to Fcgamma receptor si...
    M G MG Coppolino, M M Krause, ... A S AS Sechi

    J Cell Sci 114(Pt 23):4307-18 (2001) PMID 11739662

    We have investigated in detail the cytoskeletal events initiated upon engagement of Fc receptors in macrophages. Ena/vasodilator-stimulated phosphoprotein (VASP) proteins were recruited to phagosomes forming around opsonised particles in both primary and immortalised macrophages. Not only did the lo...
    Buy PDF
  3. Second-generation tyrosine kinase inhibitors in chronic myelogenous leukemia: before or after imatinib?
    Tefferi

    Cancer 117(2):234-7 (2011) PMID 21210471

    Buy PDF